Skip to content
Menu

Eupraxia Pharmaceuticals Inc. EPRX.TO

Full chart Compare
Set alert

Price alert · EPRX.TO

All alert types
10.56 CAD -1.09 (-9.36%)

As ofNov 16, 2026, 4:00 PM EST

10.48 Day range 11.56
7.85 52-week range 13.08
YTD
+2.33%
1 year
+13.55%
Market cap
710.35M
EPS (ttm)
-1.41
Shares out
35.62M
Forward P/E
-6.77
YTD return
+2.33%
1-year return
+13.55%
50-day average
4.23
Volume
106.98K
Avg volume
87.62K
Open
11.50
Previous close
11.65
Day's range
10.48 – 11.56
52-week range
7.85 – 13.08
Beta
1.23

5D +1.79 (+19.21%)

101112FriMonTueWedThu11.11

Key statistics

200-day average
3.86
Enterprise value
136.94M
Price / book
54.32
Free cash flow
-14.62M
Total cash
23.32M
Total debt
4.66M
Return on equity
-314.41%
Short % of float
0.07%

About Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidates are EP-104IAR, which is in a Phase III clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis; EP-104GI, which is in a Phase II clinical trial for the treatment of eosinophilic esophagitis; and EP-104, under preclinical studies for the treatment of other inflammatory joint conditions, benign structures of the esophagus, and epidural delivery. It also is involved in the development of product candidates for oncology. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.

Sector
Healthcare
Industry
Biotechnology
Country
Canada

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on EPRX.TO — it syncs with the Stock Master app.

Institution ownership

EPRX.TO institution ownership
Holder% heldSharesValueReported
Scotia Capital Inc.3.92%1,396,2816.14MSep 29, 2024
Royal Bank of Canada0.76%271,2871.19MSep 29, 2024
Bank of Montreal /CAN/0.14%49,250216.70KSep 29, 2024
Goldman Sachs Group Inc0.10%34,500151.80KSep 29, 2024
UBS Group AG0.09%33,000145.20KSep 29, 2024
180 Wealth Advisors, LLC0.04%13,00057.20KSep 29, 2024